Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Sascha Dietrich, Christina Schmidt et al.|Blood|2022Cited by 100
Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemiaMartin Kaiser, Claudia D. Baldus|Blood Cancer Journal|2011Cited by 74
Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligenceJan‐Niklas Eckardt, Jan Moritz Middeke, Waldemar Hahn et al.|npj Digital Medicine|2024Cited by 58
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestationsJan‐Niklas Eckardt, Jan Moritz Middeke, Friedrich Stölzel et al.|Journal of Hematology & Oncology|2022Cited by 58
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learningJan‐Niklas Eckardt, Jan Moritz Middeke, Christoph Röllig et al.|Haematologica|2022Cited by 47